-transparent.png){kind=logo}
The automated flow cytometry system (FCM) at Memorial Sloan-Kettering Cancer Center has been used to monitor the effect of intravesical BCG in the therapy of superficial bladder cancer. Analysis of saline bladder washings prior to therapy, weekly during the six weeks of therapy, and at follow-up examination in 2 patients, 1 responder and 1 nonresponder, provides the basis for some projections regarding the potential value of this technique.
Related Publications
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
September 1998,
Hinyokika kiyo. Acta urologica Japonica,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
April 1994,
Journal of clinical pharmacy and therapeutics,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
February 1988,
The Journal of urology,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
January 1988,
Progress in clinical and biological research,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
January 1989,
Progress in clinical and biological research,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
February 2000,
Current pharmaceutical design,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
August 2003,
Critical reviews in oncology/hematology,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
August 1992,
Urology,
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
May 2000,
Oncology (Williston Park, N.Y.),
F A Klein, and
H W Herr, and
W F Whitmore, and
C H Pinsky, and
H T Oettgen, and
M R Melamed
February 1994,
Urology,
